Dennis Jenke

Principal Consultant

Nelson Labs Europe

Newest Developments:

Rubber Oligomers C13H24 and C21H40

Proprietary Compound Screener Database

Organic Synthesis Services

Rapid Microbiology

News & Events

  • On 31 October 2017, Nelson Laboratories acquired Toxikon Europe N.V., the European division of Toxikon Corporation. Toxikon Europe’s capabilities are complementary and additive to Nelson Labs’ existing testing portfolio and, in combination, make Nelson Labs one of the premier global E&L laboratory testing platforms for the pharmaceutical and medical device industries. Press Release

  • Sterigenics International LLC Changes Name to Sotera Health LLC. Leverages the strength of Nelson Labs, Nordion and Sterigenics to deliver on its mission of Safeguarding Global Health™ Press Release

  • Toxikon Europe NV and SG Lab by Stevanato Group Announce a Strategic, Formal Partnership to Create a World-Class Scientific Service in Support of the Pharmaceutical and Biotech Industries. Press Release

  • Terumo and Toxikon Europe NV announce a Strategic Partnership by joining the expertise of both companies to service the pharmaceutical industry.  Press Release

Link to Nelson Labs USA Site
Nelson Labs Europe | Home
toxicology (acute, subchronic, and chronic toxicity, reproductive toxicity, genetic toxicology, and carcinogenicity), pharmacokinetics, toxicokinetics, bioavailability, ADME, chemical characterization, impurities analysis and synthesis, bioanalytical, and microbiology/virology, pharmaceutical, medical device, or biotech company, anticancer or antiviral compound
Nelson Labs Europe is a preclinical contract research organization. We contract and partner with biotech, pharmaceutical, and medical device industries to deliver exceptional product development services from concept to final product.